19-4117552-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3

The NM_030662.4(MAP2K2):​c.170T>A​(p.Phe57Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F57V) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

MAP2K2
NM_030662.4 missense

Scores

10
6
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.11
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr19-4117553-A-C is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.79

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP2K2NM_030662.4 linkc.170T>A p.Phe57Tyr missense_variant Exon 2 of 11 ENST00000262948.10 NP_109587.1 P36507
MAP2K2XM_006722799.3 linkc.170T>A p.Phe57Tyr missense_variant Exon 2 of 9 XP_006722862.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP2K2ENST00000262948.10 linkc.170T>A p.Phe57Tyr missense_variant Exon 2 of 11 1 NM_030662.4 ENSP00000262948.4 P36507
MAP2K2ENST00000394867.9 linkn.609T>A non_coding_transcript_exon_variant Exon 1 of 10 5
MAP2K2ENST00000599345.1 linkn.367T>A non_coding_transcript_exon_variant Exon 2 of 7 5
MAP2K2ENST00000687128.1 linkn.609T>A non_coding_transcript_exon_variant Exon 1 of 7

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
36
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
May 09, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The MAP2K2 c.170T>A (p.Phe57Tyr) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome (SNPs&GO is not captured due to low reliability index). This variant is absent from 121104 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories, nor evaluated for functional impact by in vivo/vitro studies. The Phe57 codon is conserved across species and appears to be a mutational hot spot; alterations of this codon (Phe57Cys, Phe57Ile, Phe57Leu, and Phe57val) were reported in multiple individuals diagnosed with CFC, suggesting that missense changes at this residue are not tolerated. Taken together, the variant was classified as VUS-Possibly Pathogenic until additional information becomes available. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.82
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D
M_CAP
Pathogenic
0.49
D
MetaRNN
Pathogenic
0.79
D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Uncertain
2.4
M
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-2.1
N
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.34
T
Polyphen
1.0
D
Vest4
0.73
MutPred
0.54
Gain of phosphorylation at F57 (P = 0.0845);
MVP
0.85
MPC
1.3
ClinPred
0.94
D
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.50
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121434497; hg19: chr19-4117550; API